A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in ...

IDH-mutant glioma, caused by abnormalities in a specific gene (IDH), is the most common malignant brain tumor among young ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...

Researchers have unlocked a way to grow the immune system’s “conductors” from stem cells, bringing ready-made cancer-fighting therapies a big step closer. For the first time, scientists at the Univers ...

A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Neoantigens are unique markers that distinguish only cancer cells. By adding B cell reactivity, cancer vaccines can move ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the ...